Twitxy Saved

WTec

Verified account This account is verified. Learn more

@WTec78

Father of three. "No legacy is so rich as honesty" #MAHA $ALLR all are opinions & NFA
Joined July 2022
939 Following 816 Followers 12K Posts

Latest posts 5

Pinned post

WTec Verified account @WTec78
$ALLR Something to consider with NFA…. 03/02/26 $2OM 💰 NON-convert/NON-dilute financing is precisely structured to bridge the current Phase 2 (completion + strong data) through regulatory engagement and into pivotal escalation, with clear runway through 2028.
This setup creates an optimal window to pursue BTD (on top of existing 08/2025 Fast Track ) during the funded @US_FDA meeting prep phase, maximizing speed toward approval in platinum-resistant ovarian cancer.
BTD approval is 60 days ⏳⌛️🚀
Phase2 each treatment 28 days cycle.. do they have prep-data and that’s how 20M$ was approved ?
Who would agree to take 20M$ and just sit and wait with NO DATA and PLAN in MOTION…?
Any suggestions @BioValues @IAmBiotech
@IAmBiotech @BPharmCatalyst
@ESGO_society @myESMO
@PSOGI_EC
@IJGConline @ENYGO_official
@AJOG_thegray @gynoncjnls
@oncodaily
@JCO_ASCO @oncodaily
@AmgenOncology @OncoAlert @bioAffinity
4 replies 0 reposts 28 likes 3.8K views View on X
WTec Verified account @WTec78
$GNS RS is not best efforts!
best efforts is NOT to dilute and concentrate on what’s U can do with what U got!!!! 🎪
Roger James Hamilton Verified account @rogerhamilton Nov 10
Despite our best efforts to avoid a reverse split, $GNS board has made the necessary decision to proceed with a 1-for-10 share consolidation to avoid potential delisting. We continue on our committed path of profitable operations, and building our balance sheet. In contrast to our current share price, our underlying business is the healthiest it has been.

Full PR - ir.geniusgroup.net/news-events/pr…

The Company’s shares have been trading at a price of approximately $0.10 per share over recent trading days. The NYSE American has advised the Company that it generally views trading below $0.10 per share to be abnormally low under Section 1003(f)(v) of the NYSE American Company Guide, and that it may commence delisting proceedings and immediately suspend trading at such levels.

The Board considers the consolidation a necessary step in light of this, as well as to strengthen the Company’s capital-market positioning as it advances its proposed ASX dual listing, continues to build towards operational profitability, and streamlines its share structure.
View quoted post on X